The rapidly evolving UC Cancer Institute, a close collaborator with the UC Brain Tumor Center, enjoyed some rarefied company Wednesday, as a group of 30 delegates from the French Ministry of Health and French academic hospitals stopped by to learn how UC has envisioned and constructed its cancer center. The French delegation had previously visited the National Cancer Institute in Maryland and the MD Anderson Cancer Center in Texas.

Olivier Rixe, MD, PhD, a former Parisian who is Medical Neuro-Oncologist at UCNI and Director of UC’s Experimental Therapeutics Program, is the catalyst who brought the delegation to Cincinnati.

UC’s public relations office reported that “Physicians and researchers affiliated with the UC Cancer Institute gave presentations on topics ranging from translational research (phase 1 trials, brain tumor molecular therapeutics) and the impact a unified cancer center can have on fellowship training to the importance of clinician-scientists who cross the divide between ‘researcher’ and ‘doctor’ and the role of advanced-practice nurses in patient care. UC presenters also highlighted the Cincinnati Cancer Center, a collaborative effort of the UC College of Medicine, Cincinnati Children’s Hospital Medical Center and UC Health University Hospital to develop a world-class comprehensive able to provide innovative multidisciplinary cancer research and highly specialized patient care for children and adults in our region.”